Stock Events

iShares Biotechnology 

$145.03
167
+$0+0% Today

Statistics

Day High
145.16
Day Low
144.71
52W High
145.16
52W Low
112.2
Volume
3.44
Avg. Volume
3,420
Mkt Cap
-
P/E Ratio
-
Dividend Yield
0.24%
Dividend
0.35

Upcoming

Dividends

0.24%Dividend Yield
10Y Growth
10.46%
5Y Growth
14.04%
3Y Growth
8%
1Y Growth
15.87%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0JGB.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
SPDR Biotech
XBI
Mkt Cap7.45B
SPDR S&P Biotech ETF, tracks an equal-weighted index of US biotechnology stocks, directly competing in the biotech ETF space.
VanEck Biotech
BBH
Mkt Cap451.97M
VanEck Vectors Biotech ETF, focuses on the most liquid companies in the biotech industry, offering similar exposure.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap1.15B
First Trust NYSE Arca Biotechnology Index Fund, tracks a tiered equal-weighted index of biotechnology companies.
Invesco Biotechnology & Genome
PBE
Mkt Cap256.41M
Invesco Dynamic Biotechnology & Genome ETF, uses a quantitative model to select biotech and genome companies, offering a dynamic approach to the sector.
ALPS Medical Breakthroughs
SBIO
Mkt Cap112.89M
ALPS Medical Breakthroughs ETF, focuses on small- and mid-cap biotechnology and pharmaceutical companies, targeting more speculative growth.
Principal Healthcare Innovators
BTEC
Mkt Cap15.85M
Principal Healthcare Innovators Index ETF, targets US healthcare companies, including biotech, that are primarily engaged in research and development.
Direxion Daily S&P Biotech Bull 3X Shares
LABU
Mkt Cap1.13B
Direxion Daily S&P Biotech Bull 3X Shares, offers 3x leveraged exposure to an index of US biotechnology stocks, for more aggressive investment strategies.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap131.45M
Direxion Daily S&P Biotech Bear 3X Shares, provides -3x leveraged exposure to the same index, targeting investors betting against the biotech sector.
Virtus LifeSci Biotech Products
BBP
Mkt Cap22.13M
Virtus LifeSci Biotech Products ETF, focuses on biotechnology companies with one or more drugs in Phase II or Phase III FDA clinical trials.
Virtus LifeSci Biotech Clinical Trials
BBC
Mkt Cap11.45M
Virtus LifeSci Biotech Clinical Trials ETF, invests in companies with significant capital in early-stage clinical trials, offering a unique angle on biotech investment.

About

The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Show more...
CEO
Country
US
ISIN
US4642875565

Listings